Cormorant Asset Management

Latest statistics and disclosures from Cormorant Asset Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Cormorant Asset Management

Companies in the Cormorant Asset Management portfolio as of the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Turning Point Therapeutics I (TPTX) 8.2 $213M -10% 2.4M 87.36
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) 6.4 $167M 500k 334.89
Forma Therapeutics Hldgs SHS (FMTX) 6.4 $167M 3.4M 49.26
Revolution Medicines (RVMD) 3.5 $92M 2.6M 34.80
Chemocentryx (CCXI) 3.5 $90M -38% 1.7M 54.80
Bridgebio Pharma (BBIO) 3.3 $85M -12% 2.3M 37.52
Ishares Tr Russell 2000 Etf Put Option (IWM) 2.9 $75M 500k 149.79
Sorrento Therapeutics Com New (SRNE) 2.8 $73M 6.5M 11.15
Avidity Biosciences Ord (RNA) 2.7 $70M 2.5M 27.65
Myokardia (MYOK) 2.4 $61M -25% 450k 136.33
Omeros Corporation (OMER) 2.3 $61M +116% 6.0M 10.11
Immunovant (IMVT) 2.2 $58M NEW 1.6M 35.19
Apellis Pharmaceuticals (APLS) 2.2 $56M -9% 1.9M 30.17
Acceleron Pharma (XLRN) 2.2 $56M -16% 500k 112.53

Setup an alert

Cormorant Asset Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Spdr Ser Tr S&p Biotech Put Option (XBI) 2.1 $56M 500k 111.43
Y Mabs Therapeutics (YMAB) 2.1 $54M -11% 1.4M 38.39
Zymeworks (ZYME) 2.1 $54M +109% 1.2M 46.58
Stoke Therapeutics (STOK) 2.0 $52M -9% 1.5M 33.49
Eidos Therapeutics (EIDX) 1.9 $50M -5% 993k 50.53
Mirati Therapeutics (MRTX) 1.8 $46M -45% 275k 166.05
Viela Bio (VIE) 1.7 $45M +4% 1.6M 28.08
Reata Pharmaceuticals Cl A (RETA) 1.7 $44M +12% 450k 97.42
Twist Bioscience Corp (TWST) 1.5 $38M -9% 500k 75.97
Alx Oncology Hldgs 1.4 $36M NEW 972k 37.00
Trillium Therapeutics Com New (TRIL) 1.4 $36M NEW 2.5M 14.21
Axonics Modulation Technolog (AXNX) 1.4 $35M -3% 693k 51.04
Agenus Com New (AGEN) 1.3 $34M -22% 8.5M 4.00
Biohaven Pharmaceutical Holding (BHVN) 1.2 $33M -16% 500k 65.01
Rocket Pharmaceuticals (RCKT) 1.2 $31M -6% 1.4M 22.86
Arcturus Therapeutics Hldg I (ARCT) 1.2 $30M -12% 700k 42.90
Myovant Sciences (MYOV) 1.2 $30M -14% 2.1M 14.05
Akero Therapeutics (AKRO) 1.0 $27M +45% 860k 30.79
Blueprint Medicines (BPMC) 1.0 $26M -21% 275k 92.70
Crispr Therapeutics Namen Akt (CRSP) 1.0 $25M -25% 300k 83.64
Albireo Pharma (ALBO) 0.9 $23M NEW 700k 33.37
Biontech Se Sponsored Ads (BNTX) 0.9 $22M +85% 325k 68.95
Cabaletta Bio (CABA) 0.9 $22M 2.1M 10.84
Beam Therapeutics (BEAM) 0.8 $20M 796k 24.62
Ascendis Pharma A/s Sponsored Adr (ASND) 0.7 $19M -28% 125k 154.32
Galapagos Nv Spon Adr (GLPG) 0.7 $19M +31% 130k 142.08
Axsome Therapeutics (AXSM) 0.7 $18M -28% 250k 71.25
Igm Biosciences (IGMS) 0.6 $17M -33% 225k 73.81
Zai Lab Adr (ZLAB) 0.6 $16M -24% 189k 83.17
Inspire Med Sys (INSP) 0.6 $16M -18% 120k 129.05
Kura Oncology (KURA) 0.6 $15M -28% 500k 30.64
Pliant Therapeutics (PLRX) 0.5 $14M 611k 22.20
Otonomy (OTIC) 0.5 $13M NEW 3.2M 4.05
Deciphera Pharmaceuticals (DCPH) 0.5 $13M -21% 250k 51.30
Tcr2 Therapeutics Inc cs (TCRR) 0.5 $12M NEW 600k 20.32
Uniqure Nv SHS (QURE) 0.5 $12M -26% 325k 36.83
Sarepta Therapeutics (SRPT) 0.5 $12M -22% 85k 140.44
Insmed Com Par $.01 (INSM) 0.4 $11M -22% 350k 32.14
Akouos (AKUS) 0.4 $11M 500k 22.41
Repare Therapeutics Ord (RPTX) 0.4 $11M 349k 30.77
Argenx Se Sponsored Adr (ARGX) 0.4 $11M -42% 40k 262.52
Quotient SHS (QTNT) 0.4 $10M -31% 2.0M 5.14
Harpoon Therapeutics (HARP) 0.4 $9.7M -11% 571k 16.99
Theravance Biopharma (TBPH) 0.4 $9.6M +550% 650k 14.78
Anaptysbio Inc Common (ANAB) 0.4 $9.6M -26% 650k 14.75
Health Sciences Acq Corp 2 Ord Shs 0.3 $8.8M NEW 800k 11.00
Iteos Therapeutics 0.3 $8.6M NEW 350k 24.67
Bctg Acquisition Corp 0.3 $8.4M NEW 800k 10.46
Protara Therapeutic Com Stk (TARA) 0.3 $7.6M NEW 450k 16.83
Therapeutics Acquisition Cor Com Cl A 0.3 $7.2M NEW 500k 14.38
Morphic Hldg (MORF) 0.3 $6.8M NEW 250k 27.34
Tricida (TCDA) 0.3 $6.6M -16% 728k 9.06
Allakos (ALLK) 0.2 $6.1M -62% 75k 81.45
Genetron Hldgs Ads (GTH) 0.2 $6.0M 500k 11.94
Aveo Pharmaceuticals Com New (AVEO) 0.2 $5.9M -25% 1.0M 5.94
Fs Dev Corp Com Cl A 0.2 $5.6M NEW 500k 11.20
Merus N V (MRUS) 0.2 $5.2M -28% 429k 12.00
Homology Medicines (FIXX) 0.2 $5.0M -14% 471k 10.70
Autolus Therapeutics Spon Ads (AUTL) 0.2 $4.9M -12% 422k 11.64
Kezar Life Sciences (KZR) 0.2 $4.5M -28% 932k 4.84
Vesper Healthcare Acqstn Cor Unit 99/99/9999 0.2 $4.1M NEW 400k 10.26
Atreca Cl A Com (BCEL) 0.2 $4.1M -8% 294k 13.97
Kadmon Hldgs (KDMN) 0.2 $3.9M -44% 1.0M 3.92
Eiger Biopharmaceuticals (EIGR) 0.1 $3.7M -35% 450k 8.14
Avrobio Ord (AVRO) 0.1 $3.2M -23% 244k 13.02
Gossamer Bio (GOSS) 0.1 $3.1M -28% 248k 12.41
Panacea Acquisition Corp Unit 99/99/9999 0.1 $3.0M NEW 250k 12.00
Cardiff Oncology (CRDF) 0.1 $2.5M NEW 175k 14.19
Arena Pharmaceuticals Com New (ARNA) 0.1 $2.2M -60% 30k 74.80
Precision Biosciences Ord (DTIL) 0.1 $2.1M 347k 6.16
Amarin Corp Spons Adr New (AMRN) 0.0 $1.3M -50% 300k 4.21
Orchard Therapeutics Ads (ORTX) 0.0 $1.1M 257k 4.11
Nektar Therapeutics (NKTR) 0.0 $830k -60% 50k 16.60
Minerva Neurosciences (NERV) 0.0 $759k -53% 239k 3.18
Fate Therapeutics (FATE) 0.0 $600k -70% 15k 40.00
Outlook Therapeutics *w Exp 02/18/202 (OTLKW) 0.0 $54k 417k 0.13

Past Filings by Cormorant Asset Management

SEC 13F filings are viewable for Cormorant Asset Management going back to 2013

View all past filings